Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.98
Delayed Data
As of 4:00pm ET
 +0.03 / +0.34%
Today’s Change
7.12
Today|||52-Week Range
11.63
+4.78%
Year-to-Date

Today’s Trading

Previous close8.95
Today’s open8.90
Day’s range8.75 - 9.00
Volume255,123
Average volume (3 months)375,625
Market cap$719.7M
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-875.00%
Earnings growth (this year)-17.04%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+144.57%
P/E ratioNM
Price/Sales2.72
Price/Book4.30

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc-0.03-0.31%
KANGiKang Healthcare Gro...+0.01+0.03%
ENZEnzo Biochem Inc-0.11-1.19%
GHDXGenomic Health Inc-0.34-1.17%
Data as of 4:02pm ET, 11/17/2017

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)$0.04
Annual revenue (last year)$244.1M
Annual profit (last year)-$5.7M
Net profit margin-2.34%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Scientific Officer &
VP-Operations
Steven G. Brodie
Corporate headquarters
Fort Myers, Florida

Forecasts